MetLife (NYSE:MET) PT Lowered to $82.00

MetLife (NYSE:MET – Get Free Report) had its price objective lowered by analysts at Piper Sandler from $85.00 to $82.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s target price points to a potential upside of 16.05% […]

Related Keywords

United States ,America ,Ramy Tadros ,Piper Sandler ,Strategic Blueprint ,Metlife Company Profile ,Goalvest Advisory ,Metlife Holdings ,Metlife ,Securities Exchange Commission ,Goldman Sachs Group ,Morgan Stanley ,Marcum Wealth ,Wells Fargo Company ,Metlife Inc ,Income Solutions ,Get Free Report ,Exchange Commission ,Vest Advisory ,Group Benefits ,Latin America ,Middle East ,Metlife Daily ,Nyse Met ,Met ,Finance ,59156r10 ,Lower Price Target ,